These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 743383)

  • 1. Biopharmaceutical implications of compaction and consolidation in the design of drug dosage forms.
    Rees JE
    Boll Chim Farm; 1978 Jul; 117(7):375-90. PubMed ID: 743383
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of biopharmaceutical parameters in drug development (author's transl)].
    Thoma K
    Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives in dissolution testing of conventional and novel dosage forms.
    Azarmi S; Roa W; Löbenberg R
    Int J Pharm; 2007 Jan; 328(1):12-21. PubMed ID: 17084051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partitioning phenomena in dosage form and biopharmaceutical design. II. Some partitioning considerations in dosage form design.
    Schumacher GE
    Am J Hosp Pharm; 1971 Dec; 28(12):985-8. PubMed ID: 5135196
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopharmaceutical aspects of the design of steroidal dosage forms.
    Short MP; Rhodes CT
    Pharmazie; 1973 Aug; 28(8):509-13. PubMed ID: 4593892
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of solid self-emulsifying drug delivery systems: preparation techniques and dosage forms.
    Tang B; Cheng G; Gu JC; Xu CH
    Drug Discov Today; 2008 Jul; 13(13-14):606-12. PubMed ID: 18598917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of the starting materials on bioavailability of drugs].
    Bagnaresi P; Bulgarelli D; Calvi A; Ferrarini G
    Boll Chim Farm; 1973 Feb; 112(2):83-93. PubMed ID: 4719968
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biopharmaceutical evaluation of preparations intended for the parenteral route].
    Aiache JM; Aiache S
    Boll Chim Farm; 1983 May; 122(5):213-28. PubMed ID: 6357232
    [No Abstract]   [Full Text] [Related]  

  • 9. Roll compaction/dry granulation: pharmaceutical applications.
    Kleinebudde P
    Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE
    Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
    [No Abstract]   [Full Text] [Related]  

  • 11. [The importance of micronization in the design of dosage forms I. Theoretical and biopharmaceutical aspects].
    Antal I
    Acta Pharm Hung; 2006; 76(2):95-103. PubMed ID: 17094668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.
    Möller H; Wirbitzki E
    Boll Chim Farm; 1993 Apr; 132(4):105-15. PubMed ID: 8333916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Difficulties encountered during formulation of a parenteral dosage form containing a poorly soluble drug].
    Kovács K; Orosz T; Stampf G; Antal I; Klebovich I; Ludányi K
    Acta Pharm Hung; 2009; 79(1):35-44. PubMed ID: 19526681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility behavior and biopharmaceutical classification of novel high-solubility ciprofloxacin and norfloxacin pharmaceutical derivatives.
    Breda SA; Jimenez-Kairuz AF; Manzo RH; Olivera ME
    Int J Pharm; 2009 Apr; 371(1-2):106-13. PubMed ID: 19150493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biopharmaceutical aspects of scientific research and the teaching of drug technology].
    Murav'ev IO
    Farm Zh; 1977; (2):38-45. PubMed ID: 328295
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug--excipient interaction in solid pharmaceutical dosage forms].
    Onur E
    Turk Hij Deney Biyol Derg; 1976; 36(1):88-104. PubMed ID: 960234
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral Solid Dosage Form Disintegration Testing - The Forgotten Test.
    Al-Gousous J; Langguth P
    J Pharm Sci; 2015 Sep; 104(9):2664-75. PubMed ID: 25546430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematical approach of formulation and process development using roller compaction.
    Teng Y; Qiu Z; Wen H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New formulations in dermatology].
    Fredon L; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S30-6. PubMed ID: 17563712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.